← All news
Markets
AbCellera Biologics Inc. (ABCL) Discusses Phase II Top Line Results for ABCL635 in Treatment of Moderate-to-Severe Hot Flashes - Slideshow
Covered by 1 outlet
All coverage · 2 articles
Seeking Alpha
·Aug 10, 20:38 UTC
AbCellera Biologics Inc. (ABCL) Discusses Phase II Top Line Results for ABCL635 in Treatment of Moderate-to-Severe Hot Flashes Transcript
Seeking Alpha
·Aug 10, 17:19 UTC